Henry Schein ( (HSIC) ) has released its Q4 earnings. Here is a breakdown of the information Henry Schein presented to its investors.
Henry Schein, Inc., a leading provider of healthcare solutions for dental and medical practitioners, reported its financial results for the fourth quarter and full year of 2024, showcasing a stable performance in its core markets. The company operates in the healthcare sector, offering a wide range of products and services to support office-based practitioners globally.
In its latest earnings report, Henry Schein highlighted a notable increase in operating cash flow for 2024, reaching $848 million, a significant rise from the previous year. The company also announced a new organizational structure and reportable segments aimed at providing more meaningful information for investors. The company’s strategic plan, BOLD+1, has been successfully completed, exceeding targets for high-growth, high-margin businesses.
Key financial metrics from the report include a 5.8% increase in total net sales for the fourth quarter of 2024, reaching $3.2 billion. The company’s adjusted EBITDA for the quarter was $270 million, up from $172 million in the same period of 2023. For the full year, total net sales grew by 2.7% to $12.7 billion, with non-GAAP net income rising to $605 million, or $4.74 per diluted share.
Looking ahead, Henry Schein’s management remains confident in the company’s growth prospects, with expectations of continued earnings growth in 2025. The company plans to leverage its updated BOLD+1 Strategic Plan for 2025 to 2027, focusing on expanding its product and service offerings and enhancing its e-commerce capabilities. This forward-looking strategy aims to drive sustainable growth and achieve long-term financial goals.